floxacillin has been researched along with beta-lactams in 10 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (10.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 4 (40.00) | 24.3611 |
| 2020's | 5 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Baker, S; Cadge, B; Durham, SR; Gillett, AP; Wise, R | 1 |
| Bowler, IC; Buchanan, R; Crook, D; Stoesser, N | 1 |
| Chatfield, M; Cheng, AC; Davis, JS; Fowler, VG; Howden, BP; Lipman, J; Lye, D; Nelson, J; O'Sullivan, M; Paterson, DL; Robinson, JO; Tong, SY; Van Hal, S; Yahav, D | 1 |
| Buscher, H; Gentili, S; Imani, S; Marriott, D; Sandaradura, I | 1 |
| Begg, EJ; Chin, PKL; Everts, R; Moore, GA; Zhang, M | 1 |
| Anagnostou, NA; Andresen, DN; Archuleta, S; Bak, N; Cass, A; Chatfield, MD; Cheng, AC; Davies, J; Davis, JS; Dotel, R; Ferguson, PE; Foo, H; Fowler, VG; Ghosh, N; Gray, TJ; Guy, SD; Holmes, NE; Howden, BP; Johnson, SA; Kalimuddin, S; Lye, DC; McBride, S; McKew, GL; Meagher, N; Nelson, J; O'Sullivan, MVN; Paterson, DL; Paul, M; Price, DJ; Ralph, AP; Roberts, MA; Robinson, JO; Rogers, BA; Runnegar, N; Smith, S; Sud, A; Tong, SYC; Tramontana, AR; van Hal, SJ; Walls, GB; Warner, MS; Yahav, D; Young, BE | 1 |
| Blanch Sancho, JJ; García Aragonés, L; Martínez Alfaro, E; Mateos Rodriguez, F; Segura Luque, JC; Solís García Del Pozo, J | 1 |
| Gutheil, WG; Sharma, AD | 1 |
| Al Abdali, K; Britton, PN; Howard-Jones, AR | 1 |
| Bonten, MJM; Buis, DTP; Herpers, BL; Jansen, RR; Prins, JM; Rozemeijer, W; Sieswerda, E; Sigaloff, KCE; Soetekouw, R; van der Meer, JTM; van der Vaart, TW; van Twillert, G; van Werkhoven, CH; Veenstra, J | 1 |
1 review(s) available for floxacillin and beta-lactams
| Article | Year |
|---|---|
What do beta-lactams add to vancomycin or daptomycin in the treatment of patients with methicillin-resistant
Topics: Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cloxacillin; Daptomycin; Floxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Staphylococcal Infections; Vancomycin | 2022 |
2 trial(s) available for floxacillin and beta-lactams
| Article | Year |
|---|---|
CAMERA2 - combination antibiotic therapy for methicillin-resistant Staphylococcus aureus infection: study protocol for a randomised controlled trial.
Topics: Anti-Bacterial Agents; Australia; beta-Lactams; Cefazolin; Clinical Protocols; Cloxacillin; Daptomycin; Drug Therapy, Combination; Floxacillin; Humans; Israel; Methicillin Resistance; Methicillin-Resistant Staphylococcus aureus; New Zealand; Research Design; Singapore; Staphylococcal Infections; Time Factors; Treatment Outcome; Vancomycin | 2016 |
Effect of Vancomycin or Daptomycin With vs Without an Antistaphylococcal β-Lactam on Mortality, Bacteremia, Relapse, or Treatment Failure in Patients With MRSA Bacteremia: A Randomized Clinical Trial.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Cefazolin; Cloxacillin; Daptomycin; Drug Therapy, Combination; Endocarditis, Bacterial; Female; Floxacillin; Follow-Up Studies; Humans; Male; Methicillin-Resistant Staphylococcus aureus; Middle Aged; Staphylococcal Infections; Treatment Failure; Vancomycin | 2020 |
7 other study(ies) available for floxacillin and beta-lactams
| Article | Year |
|---|---|
The influence of protein binding upon tissue fluid levels of six beta-lactam antibiotics.
Topics: Adult; Amoxicillin; Anti-Bacterial Agents; Azlocillin; beta-Lactams; Blister; Cefoxitin; Cefsulodin; Cefuroxime; Cephalosporins; Floxacillin; Humans; Imidazolidines; Male; Penicillins; Protein Binding | 1980 |
Multidrug-resistant Escherichia coli soft tissue infection investigated with bacterial whole genome sequencing.
Topics: Amoxicillin-Potassium Clavulanate Combination; Anti-Bacterial Agents; beta-Lactams; Ciprofloxacin; Diagnosis, Differential; Drug Resistance, Multiple, Bacterial; Ertapenem; Escherichia coli; Escherichia coli Infections; Floxacillin; Follow-Up Studies; Genome, Bacterial; Gentamicins; Humans; Liver Diseases; Male; Meropenem; Middle Aged; Sequence Analysis, DNA; Soft Tissue Infections; Thienamycins; Treatment Outcome; Vancomycin | 2014 |
Too much of a good thing: a retrospective study of β-lactam concentration-toxicity relationships.
Topics: Adult; Aged; Anti-Bacterial Agents; Bacterial Infections; beta-Lactams; Clostridium Infections; Cohort Studies; Drug Monitoring; Drug-Related Side Effects and Adverse Reactions; Female; Floxacillin; Humans; Incidence; Male; Meropenem; Microbial Sensitivity Tests; Middle Aged; Neurotoxicity Syndromes; Piperacillin; Retrospective Studies; Thienamycins | 2017 |
Simultaneous Determination of Cefalexin, Cefazolin, Flucloxacillin, and Probenecid by Liquid Chromatography-Tandem Mass Spectrometry for Total and Unbound Concentrations in Human Plasma.
Topics: Adjuvants, Pharmaceutic; Adolescent; Adult; Aged; Aged, 80 and over; beta-Lactams; Cefazolin; Cephalexin; Child; Chromatography, High Pressure Liquid; Drug Monitoring; Floxacillin; Humans; Limit of Detection; Middle Aged; Plasma; Probenecid; Tandem Mass Spectrometry; Young Adult | 2018 |
Synergistic Combinations of FDA-Approved Drugs with Ceftobiprole against Methicillin-Resistant Staphylococcus aureus.
Topics: Anti-Bacterial Agents; beta-Lactams; Ceftaroline; Cloxacillin; Floxacillin; Humans; Methicillin-Resistant Staphylococcus aureus; Microbial Sensitivity Tests; Staphylococcal Infections | 2023 |
Acute bacterial lymphadenitis in children: a retrospective, cross-sectional study.
Topics: Abscess; Anti-Bacterial Agents; beta-Lactams; Child; Clindamycin; Cross-Sectional Studies; Floxacillin; Humans; Lymphadenitis; Methicillin-Resistant Staphylococcus aureus; Prospective Studies; Retrospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2023 |
Comparative effectiveness of β-lactams for empirical treatment of methicillin-susceptible Staphylococcus aureus bacteraemia: a prospective cohort study.
Topics: Adult; Anti-Bacterial Agents; Bacteremia; beta-Lactams; Ceftriaxone; Cefuroxime; Floxacillin; Humans; Methicillin; Prospective Studies; Staphylococcal Infections; Staphylococcus aureus | 2023 |